Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial

Back

ESC Premium Access

Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial

Session: Subcutaneous and extravascular defibrillators: already mainstream?

Topic: Device Treatment

Speaker: Miss S. Pepplinkhuizen (Amsterdam, NL)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Miss Shari Pepplinkhuizen

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

1 presentation

0 follower

6 more presentations in this session

Defibrillation success with a second generation intercostal extravascular ICD lead and commercially available left pectoral pulse generator

Speaker: Doctor M. Burke (Chicago, US)

A comparative analysis of conduction system pacing and biventricular pacing in patients undergoing atrioventricular node ablation: a systematic review and meta-analysis

Speaker: Doctor H. Eldeeb (Leicester, GB)

Sex differences in shocks and device-related complications in subcutaneous implantable-cardioverter defibrillator patients

Speaker: Ms J. De Veld (Amsterdam, NL)

Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation

Speaker: Miss S. Pepplinkhuizen (Amsterdam, NL)

long term follow up of Implantable Cardioverter Defibrillators (ICD) in hypertrophic cardiomyopathy: is subcutaneous the way forward?

Speaker: Mr C. Monkhouse (London, GB)

Access the full session

Subcutaneous and extravascular defibrillators: already mainstream?

Speakers: Miss S. Pepplinkhuizen, Doctor M. Burke, Doctor H. Eldeeb, Ms J. De Veld, Miss S. Pepplinkhuizen...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources